The US Food and Drug Administration is exploring partnerships with other federal agencies and private stakeholders as a potential approach to implementing mandatory prescriber training for opioids without relying on its relatively blunt risk evaluation and mitigation strategy (REMS) authority, Center for Drug Evaluation and Research Director Patrizia Cavazzoni said during an 4-5 April opioid prescriber education meeting.
“Through our recent conversations with stakeholders, we have discussed alternative collaborative approaches, such as partnering with our federal colleagues, medical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?